Silence Therapeutics reported $185.47K in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
AstraZeneca USD 12.61B 225M Mar/2026
Autolus Therapeutics Ltd USD 1.65M 2.69M Mar/2026
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Novartis USD 10.07B 184M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Silence Therapeutics USD 185.47K 1.82M Jun/2025